The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study.
Varenne, Olivier
The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study. [electronic resource] - EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology Jan 2017 - 1614-1622 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
1969-6213
10.4244/EIJY15M12_02 doi
Aged
Aged, 80 and over
Drug-Eluting Stents
Female
Humans
Male
Myocardial Infarction--therapy
Percutaneous Coronary Intervention--methods
Platelet Aggregation Inhibitors--therapeutic use
Prospective Studies
Sirolimus--therapeutic use
The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study. [electronic resource] - EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology Jan 2017 - 1614-1622 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
1969-6213
10.4244/EIJY15M12_02 doi
Aged
Aged, 80 and over
Drug-Eluting Stents
Female
Humans
Male
Myocardial Infarction--therapy
Percutaneous Coronary Intervention--methods
Platelet Aggregation Inhibitors--therapeutic use
Prospective Studies
Sirolimus--therapeutic use